Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Metabolon at Biomarkers Europe 2026

Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website

Metabolon takes part in 1 session at Biomarkers Europe 2026 in Basel. Its session centres on testing, in patients suspected of or at risk of pancreatic cancer, whether signatures made of several small molecules in blood can diagnose the disease.

OrganizationBiomarkers Europe 2026 Attendance
Metabolon
Research Triangle Park, NC
Presentation & exhibition package
metabolon.com
CROs & central labsPresentation & exhibition package
Metabolomics company measuring thousands of small-molecule metabolites per sample to support biomarker discovery, drug development and population health studies.
Talk
Wed Oct 14
12:35pm–1:00pm
Prospective Diagnostic Validation of Two Plasma Multi-Metabolite Signatures in an Enrichment Design for Patients with Suspected or at Risk of Pancreatic Cancer
with National Institute of Pharmaceutical Education and Research (NIPER)
Clinical & companion diagnostic developmentGenomics, proteomics and multi-omics

Explore the full Biomarkers Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Biomarkers Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Metabolon

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction